Zifam Pyrex Myanmar Co., Ltd is share holdings of Zifam Pinnacle Pty Ltd. (Australia), Pyrex Trading Co., Ltd, Alaris Pharmaceuticals Pte. Ltd. (Singapore) and Delta Biotech Pte. Ltd. (Singapore). It was established in May 2015 as a joint venture between Zifam Pinnacle Pty Ltd.(Australia) and Pyrex Trading Co., Ltd., Myanmar. This strategic partnership combines the strength of an Australian pharmaceutical organization with a TGA-approved manufacturing facility in Sydney and a Myanmar company with an established nationwide distribution network and more than 25 years of business experience and market presence.

The establishment of Zifam Pyrex Myanmar reflects a shared commitment to delivering high-quality, safe, and reliable pharmaceutical products that meet both local healthcare needs and international quality expectations.

Our state-of-the-art manufacturing facility is designed and operated in compliance with international Good Manufacturing Practices (GMP), ensuring consistent standards of quality, safety, and efficacy across all products and manufacturing operations.

The manufacturing site is strategically located at Lot C6, Zone A, Thilawa Special Economic Zone (SEZ), Thanlyin and Kyauk Tan Township, Yangon, Myanmar, approximately 30 kilometers from Yangon City. Situated on a 17,000 square meter (4.2-acre) site, the facility is developed within a physically segregated, green, and pollution-free environment suitable for pharmaceutical manufacturing operations.

The facility is supported by robust infrastructure designed to maintain operational efficiency and GMP compliance, including:

• Permanent internal roads
• Covered drainage systems
• Pretreated raw water supply systems
• Reliable electrical power supply
• Dedicated effluent treatment plant (ETP)

Zifam Pyrex Myanmar’s manufacturing operations are organized into dedicated production blocks to ensure effective process segregation and product integrity:

• Beta-Lactam Facility: 5,090 SQM
• General Block Facility: 2,271 SQM

These dedicated facilities support the manufacturing of a broad range of pharmaceutical dosage forms under controlled and compliant manufacturing conditions.

By integrating advanced manufacturing capability, robust quality systems, technical expertise, and strategic infrastructure, Zifam Pyrex Myanmar continues to strengthen its position as a reliable pharmaceutical manufacturer committed to supporting healthcare systems locally and internationally.